The August 2019 Edition of the Crystallography Times Newsletter is Now Online

Thursday, August 22, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Crystallography Times vol. 11, No. 8, from Rigaku, focusing on single crystal X-ray diffraction, is available from the company's website.

THE WOODLANDS, Texas, Aug. 21, 2019 /PRNewswire-PRWeb/ -- The latest edition of Crystallography Times from Rigaku

Corporation has been published and is now available on the company's global website.

Crystallography Times is a monthly electronic newsletter published by Rigaku focusing on single crystal X-ray diffraction and serves the X-ray analysis community by presenting the latest news and crystallographic research.

"Crystallography in the News" is a monthly collection of the latest news and developments, highlighting the latest research findings in small molecule and protein crystallography and X-ray diffraction from around the world.

One news article describes an experimental vaccine against respiratory syncytial virus (RSV), one of the leading causes of infectious disease deaths in infants, that has shown early promise in a Phase 1 human clinical trial. Using protein crystallography, a team of researchers (including The University of Texas at Austin's Jason McLellan) reported that one dose of their vaccine candidate elicited large increases in RSV-neutralizing antibodies that were sustained for several months.

Another news item reports that by using X-ray crystallography, researchers in Japan and the U.K. have uncovered an unusual protein activity in rice that can could pave the way for disease-resistant rice crops, giving them an advantage against trice blast disease, a major threat to rice production around the world.

The Product Spotlight in the current issue presents the Rigaku HyPix-Arc 150° curved Hybrid Photon Counting (HPC) X-ray detector for single crystal diffraction applications. The detector has the highest 2? range at a single position available for the home lab, enabling the collection of more data in a single exposure with less reflection profile distortion.

The "Lab in the Spotlight" feature highlights the Department of Chemistry at Emory University where, June of 2017, the first Rigaku XtaLAB Synergy-S diffraction system in the Western Hemisphere was installed. In just over two years, the instrument, at the guidance of Facilities Director John Bacsa, has produced over 1000 structures.

The new book review covers Bottle of Lies: The Inside Story of the Generic Drug Boom by Katherine Eban. The book details the author's investigation of the widespread use of generic drugs, revealing fraud and potentially life-threatening dangers on a global scale.

Also included are 24 recently published scientific papers, a schedule of upcoming events, and access to the Rigaku Oxford Diffraction user forum.

Crystallography Times is published monthly. Readers can subscribe to the newsletter or view the current issue online at https://www.rigaku.com/subscribe.

About Rigaku Since its inception in Japan in 1951, Rigaku has been at the forefront of analytical and industrial instrumentation technology. Rigaku and its subsidiaries form a global group focused on general-purpose analytical instrumentation and the life sciences. With hundreds of major innovations to their credit, Rigaku companies are world leaders in X-ray spectrometry, diffraction, and optics, as well as small molecule and protein crystallography and semiconductor metrology. Today, Rigaku employs over 1,400 people in the manufacturing and support of its analytical equipment, which is used in more than 90 countries around the world supporting research, development, and quality assurance activities. Throughout the world, Rigaku continuously promotes partnerships, dialog, and innovation within the global scientific and industrial communities.

For further information, contact:

Michael Nelson Global Marketing Coordinator Rigaku Corporation michael.nelson(at)rigaku.com

 

SOURCE Rigaku



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store